(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MYO10 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO MYO10 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYO10 mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression ISO Myo10 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of MYO10 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO MYO10 (Homo sapiens) 6480464 Estradiol affects the expression of MYO10 mRNA CTD PMID:14699072 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of MYO10 mRNA CTD PMID:20068009 17beta-estradiol increases expression ISO MYO10 (Homo sapiens) 6480464 Estradiol results in increased expression of MYO10 mRNA CTD PMID:19619570 and PMID:31614463 17beta-estradiol multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MYO10 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO MYO10 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of MYO10 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYO10 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MYO10 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Myo10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MYO10 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Myo10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYO10 mRNA CTD PMID:16120747 and PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MYO10 mRNA CTD PMID:19619570 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of MYO10 mRNA CTD PMID:21346803 2-palmitoylglycerol increases expression ISO MYO10 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of MYO10 mRNA CTD PMID:37199045 3,4-dichloroaniline increases expression ISO MYO10 (Homo sapiens) 6480464 3 and 4-dichloroaniline results in increased expression of MYO10 mRNA CTD PMID:24172598 4,4'-diaminodiphenylmethane increases expression ISO Myo10 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of MYO10 mRNA CTD PMID:18648102 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of MYO10 mRNA CTD PMID:31881176 acrolein multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MYO10 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MYO10 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO MYO10 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of MYO10 mRNA CTD PMID:21641981 aflatoxin B1 affects methylation ISO MYO10 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of MYO10 intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO MYO10 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of MYO10 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO MYO10 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of MYO10 mRNA CTD PMID:22100608 and PMID:32234424 Aflatoxin B2 alpha increases methylation ISO MYO10 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of MYO10 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO MYO10 (Homo sapiens) 6480464 Tretinoin results in decreased expression of MYO10 mRNA CTD PMID:21934132 alpha-pinene multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MYO10 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MYO10 mRNA CTD PMID:32699268 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of MYO10 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO MYO10 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of MYO10 mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO MYO10 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MYO10 mRNA] CTD PMID:32406909 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MYO10 gene CTD PMID:28931070 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of MYO10 mRNA CTD PMID:36841081 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA CTD PMID:33854195 benzo[a]pyrene decreases expression ISO Myo10 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of MYO10 mRNA CTD PMID:19770486 more ... benzo[a]pyrene increases expression ISO MYO10 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MYO10 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO MYO10 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MYO10 intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO MYO10 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MYO10 mRNA CTD PMID:22316170 and PMID:26238291 benzo[a]pyrene diol epoxide I decreases expression ISO MYO10 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20382639 bisphenol A decreases expression ISO MYO10 (Homo sapiens) 6480464 bisphenol A results in decreased expression of MYO10 mRNA CTD PMID:20678512 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MYO10 mRNA CTD PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MYO10 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MYO10 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO Myo10 (Mus musculus) 6480464 bisphenol A results in increased expression of MYO10 mRNA CTD PMID:21932408 and PMID:26063408 bisphenol A multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of MYO10 protein CTD PMID:31629898 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of MYO10 mRNA CTD PMID:19167457 CGP 52608 multiple interactions ISO MYO10 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MYO10 gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of MYO10 mRNA CTD PMID:23125180 chloroprene decreases expression ISO Myo10 (Mus musculus) 6480464 Chloroprene results in decreased expression of MYO10 mRNA CTD PMID:23125180 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA CTD PMID:33854195 cisplatin multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of MYO10 mRNA and [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of MYO10 mRNA CTD PMID:27392435 and PMID:30871063 cisplatin decreases expression ISO MYO10 (Homo sapiens) 6480464 Cisplatin results in decreased expression of MYO10 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO MYO10 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of MYO10 mRNA CTD PMID:19320972 copper(II) sulfate affects expression ISO MYO10 (Homo sapiens) 6480464 Copper Sulfate affects the expression of MYO10 mRNA CTD PMID:19549813 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MYO10 mRNA CTD PMID:21266533 diuron increases expression ISO MYO10 (Homo sapiens) 6480464 Diuron metabolite results in increased expression of MYO10 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO MYO10 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects methylation EXP 6480464 Doxorubicin affects the methylation of MYO10 gene CTD PMID:28962528 doxorubicin increases expression ISO MYO10 (Homo sapiens) 6480464 Doxorubicin results in increased expression of MYO10 mRNA CTD PMID:30031762 entinostat increases expression ISO MYO10 (Homo sapiens) 6480464 entinostat results in increased expression of MYO10 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO Myo10 (Mus musculus) 6480464 epoxiconazole results in decreased expression of MYO10 mRNA CTD PMID:35436446 ethanol multiple interactions ISO Myo10 (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of MYO10 mRNA CTD PMID:30319688 ethanol increases expression ISO Myo10 (Mus musculus) 6480464 Ethanol results in increased expression of MYO10 mRNA CTD PMID:30319688 folic acid affects expression ISO MYO10 (Homo sapiens) 6480464 Folic Acid affects the expression of MYO10 mRNA CTD PMID:17320366 FR900359 affects phosphorylation ISO MYO10 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of MYO10 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MYO10 mRNA CTD PMID:33387578 glycidyl methacrylate increases expression ISO MYO10 (Homo sapiens) 6480464 glycidyl methacrylate results in increased expression of MYO10 protein CTD PMID:36641056 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA CTD PMID:33854195 glyphosate increases methylation EXP 6480464 Glyphosate results in increased methylation of MYO10 gene CTD PMID:31011160 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA CTD PMID:33854195 inulin multiple interactions ISO Myo10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MYO10 mRNA CTD PMID:36331819 Lasiocarpine increases expression ISO MYO10 (Homo sapiens) 6480464 lasiocarpine results in increased expression of MYO10 mRNA CTD PMID:32234424 leflunomide increases expression ISO MYO10 (Homo sapiens) 6480464 leflunomide results in increased expression of MYO10 mRNA CTD PMID:28988120 lipopolysaccharide increases expression ISO MYO10 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of MYO10 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO MYO10 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MYO10 mRNA CTD PMID:35811015 menadione affects expression ISO MYO10 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of MYO10 mRNA CTD PMID:20044591 mercury dibromide increases expression ISO MYO10 (Homo sapiens) 6480464 mercuric bromide results in increased expression of MYO10 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO MYO10 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO10 mRNA CTD PMID:27188386 methoxyacetic acid multiple interactions ISO MYO10 (Homo sapiens) 6480464 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of MYO10 mRNA] CTD PMID:15103026 methylmercury chloride increases expression ISO MYO10 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of MYO10 mRNA CTD PMID:28001369 methylseleninic acid decreases expression ISO MYO10 (Homo sapiens) 6480464 methylselenic acid results in decreased expression of MYO10 mRNA CTD PMID:18548127 mitomycin C affects response to substance ISO MYO10 (Homo sapiens) 6480464 MYO10 protein affects the susceptibility to Mitomycin CTD PMID:16217747 nickel sulfate increases expression ISO MYO10 (Homo sapiens) 6480464 nickel sulfate results in increased expression of MYO10 mRNA CTD PMID:22714537 ozone multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MYO10 mRNA more ... CTD PMID:32699268 p-chloromercuribenzoic acid multiple interactions ISO MYO10 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO10 mRNA CTD PMID:27188386 paracetamol affects expression ISO Myo10 (Mus musculus) 6480464 Acetaminophen affects the expression of MYO10 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MYO10 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO Myo10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MYO10 mRNA CTD PMID:36331819 phenol red multiple interactions ISO MYO10 (Homo sapiens) 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of MYO10 protein CTD PMID:31629898 phenylmercury acetate increases expression ISO MYO10 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of MYO10 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO MYO10 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO10 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO Myo10 (Mus musculus) 6480464 pirinixic acid results in decreased expression of MYO10 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO MYO10 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MYO10 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO MYO10 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYO10 mRNA CTD PMID:22079256 promegestone multiple interactions ISO MYO10 (Homo sapiens) 6480464 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of MYO10 mRNA] CTD PMID:15103026 promegestone increases expression ISO MYO10 (Homo sapiens) 6480464 Promegestone results in increased expression of MYO10 mRNA CTD PMID:15103026 raloxifene affects expression ISO MYO10 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of MYO10 mRNA CTD PMID:14699072 rotenone decreases expression ISO MYO10 (Homo sapiens) 6480464 Rotenone results in decreased expression of MYO10 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO MYO10 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MYO10 mRNA CTD PMID:35811015 Salinomycin decreases expression ISO MYO10 (Homo sapiens) 6480464 salinomycin results in decreased expression of MYO10 mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO MYO10 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO Myo10 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of MYO10 mRNA CTD PMID:19073995 sodium arsenite increases expression ISO MYO10 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MYO10 mRNA CTD PMID:22714537 sodium arsenite affects methylation ISO MYO10 (Homo sapiens) 6480464 sodium arsenite affects the methylation of MYO10 gene CTD PMID:28589171 sotorasib multiple interactions ISO MYO10 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYO10 mRNA CTD PMID:36139627 sunitinib increases expression ISO MYO10 (Homo sapiens) 6480464 Sunitinib results in increased expression of MYO10 mRNA CTD PMID:31533062 tebufenpyrad increases expression ISO MYO10 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MYO10 mRNA CTD PMID:33512557 tert-butyl hydroperoxide increases expression ISO MYO10 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of MYO10 mRNA CTD PMID:15336504 tetrachloromethane affects expression ISO Myo10 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of MYO10 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MYO10 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MYO10 mRNA CTD PMID:31150632 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA CTD PMID:33854195 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MYO10 mRNA CTD PMID:34492290 trametinib multiple interactions ISO MYO10 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYO10 mRNA CTD PMID:36139627 trichostatin A decreases expression ISO MYO10 (Homo sapiens) 6480464 trichostatin A results in decreased expression of MYO10 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO MYO10 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO10 mRNA CTD PMID:27188386 trichostatin A increases expression ISO MYO10 (Homo sapiens) 6480464 trichostatin A results in increased expression of MYO10 mRNA CTD PMID:24935251 and PMID:26272509 triptonide decreases expression ISO Myo10 (Mus musculus) 6480464 triptonide results in decreased expression of MYO10 mRNA CTD PMID:33045310 troglitazone increases expression ISO MYO10 (Homo sapiens) 6480464 troglitazone results in increased expression of MYO10 mRNA CTD PMID:19140230 troglitazone decreases expression ISO Myo10 (Mus musculus) 6480464 troglitazone results in decreased expression of MYO10 mRNA CTD PMID:28973697 urethane decreases expression ISO MYO10 (Homo sapiens) 6480464 Urethane results in decreased expression of MYO10 mRNA CTD PMID:28818685 valproic acid affects expression ISO MYO10 (Homo sapiens) 6480464 Valproic Acid affects the expression of MYO10 mRNA CTD PMID:25979313 and PMID:26272509 valproic acid multiple interactions ISO MYO10 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 valproic acid increases expression ISO MYO10 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MYO10 mRNA CTD PMID:19101580 more ... vorinostat decreases expression ISO MYO10 (Homo sapiens) 6480464 vorinostat results in decreased expression of MYO10 mRNA CTD PMID:27188386